Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Clinical trial NCT03104491 · RECRUITING

Trial details

NCT number: NCT03104491
Sponsor: Leland Metheny
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia

Start date: 2017-07-31
Primary completion: 2025-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.